Regenxbio Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Hello, everyone. Thank you for joining our Second Virtual Health Care Conference. My name is Gena Wang. I'm Senior Analyst at the Barclays. First, I wish everyone, stay healthy, and I would like to thank all the participants, investors, companies and especially the event team and corporate access team who made this virtual health care conference possible. With that, I would like to introduce our next presenting companies REGENXBIO.
Today with us, we have Steve Pakola, Chief Medical Officer; Olivier Danos, Chief Scientific Officer. So with that, maybe I hand over to you, Steve, to give a few minute high-level description over the company and then we can go to the Q&A.
Sure. Sounds great. First, Gena, thanks for having Olivier and I here. We're very excited about our progress across our platform programs.
So it's a great opportunity to always to sit down with you and have some Q&A across those programs. So the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |